Medical Cannabis Dose Patterns and Symptom Control in Pancreatic Cancer
medical cannabis research: CANPAN pilot data suggest modest THC dosing may relate to anxiety, insomnia, and multi-symptom improvement in pancreatic cancer, while also exposing major feasibility challenges in advanced cancer research. It keeps the…
What CANPAN Suggests About THC Dose and Symptoms in Pancreatic Cancer
medical cannabis research: A small CANPAN analysis links higher daily THC exposure with better anxiety and insomnia scores in pancreatic cancer, while also exposing major feasibility and missing-data challenges for future trials. It keeps the evidence…
Intranasal lipid carrier cannabidiol for Dravet and Lennox-Gastaut syndromes remains promising but unproven
medical cannabis research: A new review argues that intranasal nanostructured lipid carrier CBD could improve brain delivery for severe pediatric epilepsies, but the evidence remains preclinical and not yet patient-ready. It keeps the evidence readable…
Nose to Brain CBD Nanocarriers for Dravet and Lennox Gastaut Syndromes
medical cannabis research: A new review argues that intranasal nanostructured lipid CBD could improve brain delivery for severe childhood epilepsies, but the concept remains preclinical and unproven in children. It keeps the evidence readable for…
Intranasal CBD Nanocarriers for Dravet and Lennox Gastaut Syndromes
medical cannabis research: A new review argues that intranasal nanostructured lipid CBD could improve brain delivery for severe childhood epilepsies, but human pediatric safety, dosing, and efficacy data remain absent. It keeps the evidence readable for…
Intranasal CBD Nanocarriers for Dravet and Lennox-Gastaut Syndromes, Promise Before Proof
medical cannabis research: A 2026 review argues that intranasal nanostructured lipid CBD could improve brain delivery for severe childhood epilepsies, but the clinical evidence remains preclinical and translational. It keeps the evidence readable for…
Weekly Medical Cannabis & Science Literature Radar: September 13, 2026
medical cannabis research radar: A comprehensive weekly literature index analyzing 20 newly published medical cannabis, cannabinoid, and GLP-1 research studies, clinical trial protocols, and regulatory updates. It keeps the evidence readable for patients…
Cannabis Plant Anatomy: What the Microscopy Actually Shows About Where Cannabinoids Come From
Cannabis plant anatomy, read from the microscopy literature rather than the infographics: cannabinoids and most terpenes are made and stored in glandular trichomes on the surface of female floral bracts, not within leaf, stem, or root tissue. Stalked…
Where Cannabinoid Receptors Actually Live: A Working Map of CB1 and CB2 Across the Human Body
CB1 and CB2 receptor distribution is the anatomical foundation under every clinical question in cannabis medicine, and most summaries of it are vaguer than the primary data require. This page maps both receptors from the original cloning and…
What Cannabinoid Receptors Do Inside Immune Cells, and Why That Is Not the Same as Fighting Infection
CB2 receptors and innate immunity are genuinely linked, but not in the way most consumer writing suggests: cannabinoid receptors modulate inflammatory signaling rather than recognizing pathogens. This page separates the established receptor biology from…